Anita Saraf
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anita Saraf has a total of 149 co-authors. Here are the top co-authors by number of shared publications:
Wendy Book
Division of Cardiology, Department of Medicine, Emory University Department of Medicine, Atlanta, GA 30322, United States of America
3 shared publicationsArshed Quyyumi
Division of Cardiology, Department of Medicine, Emory University Department of Medicine, Atlanta, GA 30322, United States of America
2 shared publicationsArvind Hoskoppal
Division of Cardiology, Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA 15312, United States of America; Heart Institute, UPMC Children's Hospital of Pittsburgh and UPMC Heart and Vascular Institute, Pittsburgh, PA 15312, United States of America; Division of Cardiology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, United States of America
2 shared publicationsBryan H. Goldstein
Heart Institute, UPMC Children's Hospital of Pittsburgh and UPMC Heart and Vascular Institute, Pittsburgh, Pennsylvania, USA; Division of Cardiology, Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
2 shared publicationsCarley Bright
Heart Institute, UPMC Children's Hospital of Pittsburgh and UPMC Heart and Vascular Institute, Pittsburgh, Pennsylvania, USA; Division of Cardiology, Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
2 shared publicationsFred Rodriguez
2 shared publications
Latest Publications
- Open Access
- 13 July 2026
- Published by Wiley in Advanced Science
- Vol. 13 (55) , e23820
Cyclic Mechanical Loading of Cardiomyocytes via Pressure‐Driven Non‐Planar Membrane Deformation in a Bioreactor System
We introduce a novel bioreactor system that applies cyclic strain through controlled non‐planar membrane deformation. The membrane deformation is driven by tunable pressure profiles spanning clinically reported end‐diastolic pressure ranges observed in physiological and disease‐associated conditions. Applied pressure was quantitatively related to spatial membrane strain through three‐dimensional membrane reconstruction, enabling characterization of the mechanical environment at the cell–substrate interface. Human induced pluripotent stem cell‐derived cardiomyocytes (hiPSC‐CMs) are cyclically loaded for three days and analyzed for structural, functional, and transcriptomic responses. The bioreactor system preserves cellular viability under pressures ranging from 0–15 mmHg. Cells exposed to physiological preloads (5 and 10 mmHg) exhibit functional and transcriptional changes associated with cardiomyocyte maturation, including cell elongation and altered contractile waveform kinetics, while those under pathological preloading conditions (15 mmHg) show activation of stress‐related and catabolic signaling pathways commonly reported in mechanical overload and heart failure models. This platform enables precise modeling of myocardial biomechanics and offers a robust tool for investigating cardiomyocyte response across health and disease states.
- 13 July 2026
- Published by Wiley in Advanced Science
- Vol. 13 (55) , e23820
Open AccessCyclic Mechanical Loading of Cardiomyocytes via Pressure‐Driven Non‐Planar Membrane Deformation in a Bioreactor System
We introduce a novel bioreactor system that applies cyclic strain through controlled non‐planar membrane deformation. The membrane deformation is driven by tunable pressure profiles spanning clinically reported end‐diastolic pressure ranges observed in physiological and disease‐associated conditions. Applied pressure was quantitatively related to spatial membrane strain through three‐dimensional membrane reconstruction, enabling characterization of the mechanical environment at the cell–substrate interface. Human induced pluripotent stem cell‐derived cardiomyocytes (hiPSC‐CMs) are cyclically loaded for three days and analyzed for structural, functional, and transcriptomic responses. The bioreactor system preserves cellular viability under pressures ranging from 0–15 mmHg. Cells exposed to physiological preloads (5 and 10 mmHg) exhibit functional and transcriptional changes associated with cardiomyocyte maturation, including cell elongation and altered contractile waveform kinetics, while those under pathological preloading conditions (15 mmHg) show activation of stress‐related and catabolic signaling pathways commonly reported in mechanical overload and heart failure models. This platform enables precise modeling of myocardial biomechanics and offers a robust tool for investigating cardiomyocyte response across health and disease states.
- Open Access
- 24 February 2026
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 11 (13)
Single-cell spatial transcriptomics reveals hepatocyte reprogramming in Fontan-associated liver disease
Fontan-associated liver disease (FALD) is a frequent complication in single-ventricle patients palliated with the Fontan operation. FALD severity can impact clinical decisions; however, the pathophysiology of FALD progression is unknown. Single-cell spatial transcriptomics (ST) was performed on liver explant tissue sections from FALD patients with early ( n = 1) and advanced fibrosis ( n = 1) using CosMx Spatial Molecular Imaging with in situ hybridization of 6000 genes. Immunofluorescence for liver zonation and cellular stress markers was performed to confirm protein expression based on ST analysis in additional FALD tissues ( n = 18). Unbiased clustering yielded 12 liver cell types, comprising 6 subtypes of hepatocytes. FALD with advanced fibrosis demonstrated expansion of mid-zonal hepatocytes, accompanied by loss of zonal markers characteristic of canonical pericentral and periportal hepatocytes. A subset of hepatocytes in advanced FALD demonstrated increased cellular stress and a redundant zonal phenotype, which we have termed zonally ambiguous and stressed hepatocytes. CellChat analysis revealed that ectopic WNT2 signaling is likely driving disrupted hepatocyte zonation. To corroborate these bioinformatic findings, we performed immunofluorescent staining of FALD specimens, which confirmed a disruption of liver zonation, and a significant increase in heat shock protein 70 (HSP70). Lastly, HSP70 expression strongly correlated with the congestive hepatic fibrosis (CHF) score. Thus, single-cell ST has identified a population of hepatocytes with features of cellular stress and redundant zonal gene expression specific to advanced FALD. Further studies on hepatocyte metabolic function in Fontan patients will lead to a greater understanding of FALD development and progression during chronic maladaptation.
- 24 February 2026
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 11 (13)
Open AccessSingle-cell spatial transcriptomics reveals hepatocyte reprogramming in Fontan-associated liver disease
Fontan-associated liver disease (FALD) is a frequent complication in single-ventricle patients palliated with the Fontan operation. FALD severity can impact clinical decisions; however, the pathophysiology of FALD progression is unknown. Single-cell spatial transcriptomics (ST) was performed on liver explant tissue sections from FALD patients with early ( n = 1) and advanced fibrosis ( n = 1) using CosMx Spatial Molecular Imaging with in situ hybridization of 6000 genes. Immunofluorescence for liver zonation and cellular stress markers was performed to confirm protein expression based on ST analysis in additional FALD tissues ( n = 18). Unbiased clustering yielded 12 liver cell types, comprising 6 subtypes of hepatocytes. FALD with advanced fibrosis demonstrated expansion of mid-zonal hepatocytes, accompanied by loss of zonal markers characteristic of canonical pericentral and periportal hepatocytes. A subset of hepatocytes in advanced FALD demonstrated increased cellular stress and a redundant zonal phenotype, which we have termed zonally ambiguous and stressed hepatocytes. CellChat analysis revealed that ectopic WNT2 signaling is likely driving disrupted hepatocyte zonation. To corroborate these bioinformatic findings, we performed immunofluorescent staining of FALD specimens, which confirmed a disruption of liver zonation, and a significant increase in heat shock protein 70 (HSP70). Lastly, HSP70 expression strongly correlated with the congestive hepatic fibrosis (CHF) score. Thus, single-cell ST has identified a population of hepatocytes with features of cellular stress and redundant zonal gene expression specific to advanced FALD. Further studies on hepatocyte metabolic function in Fontan patients will lead to a greater understanding of FALD development and progression during chronic maladaptation.
- 19 February 2026
- Published by SAGE Publications in Tissue Engineering Part B: Reviews
Evolution of Cardiac Models Toward Recreating Biologically Relevant Multiaxial Mechanical Stimuli
Understanding and recreating biomechanical forces in in vitro cultures is integral to regenerating cardiac tissue and finding novel therapies for cardiovascular disease. Mechanical forces influence cardiac physiology from a microscopic cellular scale to the global function of the heart. Here, we will review the mechanical forces within the heart as understood clinically and evaluate in vitro device designs that mimic these mechanical forces at a cellular and tissue level. We will further follow the evolution of bioreactors toward recapitulating multiaxial mechanical forces as they are experienced in vivo and understand the current limitations associated with in vitro systems in the context of recreating in vivo cardiac physiology.
- 19 February 2026
- Published by SAGE Publications in Tissue Engineering Part B: Reviews
Evolution of Cardiac Models Toward Recreating Biologically Relevant Multiaxial Mechanical Stimuli
Understanding and recreating biomechanical forces in in vitro cultures is integral to regenerating cardiac tissue and finding novel therapies for cardiovascular disease. Mechanical forces influence cardiac physiology from a microscopic cellular scale to the global function of the heart. Here, we will review the mechanical forces within the heart as understood clinically and evaluate in vitro device designs that mimic these mechanical forces at a cellular and tissue level. We will further follow the evolution of bioreactors toward recapitulating multiaxial mechanical forces as they are experienced in vivo and understand the current limitations associated with in vitro systems in the context of recreating in vivo cardiac physiology.
- Open Access
- 25 September 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (29) , 105142
Autoimmune Reaction and the Management of Recurrent Bioprosthetic Pulmonary Valve Dysfunction
- 25 September 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (29) , 105142
Open AccessAutoimmune Reaction and the Management of Recurrent Bioprosthetic Pulmonary Valve Dysfunction
- Open Access
- 27 June 2025
- Published by MDPI AG in Therapeutics
- Vol. 2 (3) , 11
Novel 2D/3D Hybrid Organoid System for High-Throughput Drug Screening in iPSC Cardiomyocytes
Background: Human induced pluripotent stem cell cardiomyocytes (hiPSC-CMs) allow for high-throughput evaluation of cardiomyocyte (CM) physiology in health and disease. While multimodality testing provides a large breadth of information related to electrophysiology, contractility, and intracellular signaling in small populations of iPSC-CMs, current technologies for analyzing these parameters are expensive and resource-intensive. Methods: We have designed a novel 2D/3D hybrid organoid system that can harness optical imaging techniques to assess electromechanical properties and calcium dynamics across CMs in a high-throughput manner. We validated our methods using a doxorubicin-based system, as the drug has well-characterized cardiotoxic, pro-arrhythmic effects. Results: This novel hybrid system provides the functional benefit of 3D organoids while minimizing optical interference from multilayered cellular systems through our cell-culture techniques that propagate organoids outwards into 2D iPSC-CM sheets. The organoids recapitulate contractile forces that are more robust in 3D structures and connectivity, while 2D CMs facilitate analysis at an individual cellular level, which recreated numerous doxorubicin-induced electrophysiologic and propagation abnormalities. Conclusions: Thus, we have developed a novel 2D/3D hybrid organoid model that employs an integrated optical analysis platform to provide a reliable high-throughput method for studying cardiotoxicity, providing valuable data on calcium, contractility, and signal propagation.
- 27 June 2025
- Published by MDPI AG in Therapeutics
- Vol. 2 (3) , 11
Open AccessNovel 2D/3D Hybrid Organoid System for High-Throughput Drug Screening in iPSC Cardiomyocytes
Background: Human induced pluripotent stem cell cardiomyocytes (hiPSC-CMs) allow for high-throughput evaluation of cardiomyocyte (CM) physiology in health and disease. While multimodality testing provides a large breadth of information related to electrophysiology, contractility, and intracellular signaling in small populations of iPSC-CMs, current technologies for analyzing these parameters are expensive and resource-intensive. Methods: We have designed a novel 2D/3D hybrid organoid system that can harness optical imaging techniques to assess electromechanical properties and calcium dynamics across CMs in a high-throughput manner. We validated our methods using a doxorubicin-based system, as the drug has well-characterized cardiotoxic, pro-arrhythmic effects. Results: This novel hybrid system provides the functional benefit of 3D organoids while minimizing optical interference from multilayered cellular systems through our cell-culture techniques that propagate organoids outwards into 2D iPSC-CM sheets. The organoids recapitulate contractile forces that are more robust in 3D structures and connectivity, while 2D CMs facilitate analysis at an individual cellular level, which recreated numerous doxorubicin-induced electrophysiologic and propagation abnormalities. Conclusions: Thus, we have developed a novel 2D/3D hybrid organoid model that employs an integrated optical analysis platform to provide a reliable high-throughput method for studying cardiotoxicity, providing valuable data on calcium, contractility, and signal propagation.
- Open Access
Hypomorphic NOTCH1 Expression Alters Cardiomyocyte Cellular Architecture in Hypoplastic Left Heart Syndrome
Summary: NOTCH1 is a protein involved in cardiac development and mutations in NOTCH1 are implicated in left sided congenital heart disease, including hypoplastic left heart syndrome (HLHS). Therapeutic advances for HLHS patients have been hampered by the absence of suitable experimental models. Here, using human induced pluripotent stem cells (hiPSCs), we have generated a series of CRISPR-edited complex heterozygous hypomorphic mutations in NOTCH1 that recapitulate mutations seen in HLHS patients. These cells demonstrate the downregulation of genes associated with mitochondria, the actin cytoskeleton, and cardiomyocyte development. In addition, these hypomorphic NOTCH1 hiPSCs cells showed an increased propensity to differentiate towards non-cardiomyocyte lineages such as fibroblasts and smooth muscle cells, a finding confirmed in HLHS patient-derived myocardial tissue. Abnormalities in sarcomeric and mitochondrial architecture contributed to decreased ATP production, abnormal calcium transients, and reduced contractility. Using a split nano-luciferase system as a NOTCH1 intracellular reporter, we screened a library of FDA-approved compounds. Auranofin, an agent currently employed for rheumatoid arthritis, was identified as a candidate drug that could rescue impaired differentiation and contractility seen in the hypomorphic NOTCH1 model. These findings point to cell-autonomous abnormalities in hypomorphic NOTCH1 pre-cardiomyocyte cells that can be leveraged to identify potential therapeutic strategies for patients with severe congenital cardiac abnormalities. Highlights: CRISPR edited and patient-derived iPSCs with hypomorphic NOTCH1 expression were used to characterize a cell-based model of hypoplastic left heart syndrome. Hypomorphic NOTCH1 iPSCs have abnormalities in pathways associated with mitochondrial function, actin cytoskeleton, and cardiomyocyte development. Hypomorphic NOTCH1 iPSCs have less pluripotency and tend to skew differentiation away from cardiomyocytes and towards fibroblasts and smooth muscle cells. NOTCH1 is required for cardiac cytoskeletal and mitochondrial architecture, and to preserve contractility and ATP production. A high-throughput drug screen identified auranofin as an agent that may benefit patients with hypoplastic left heart syndrome.
Open AccessHypomorphic NOTCH1 Expression Alters Cardiomyocyte Cellular Architecture in Hypoplastic Left Heart Syndrome
Summary: NOTCH1 is a protein involved in cardiac development and mutations in NOTCH1 are implicated in left sided congenital heart disease, including hypoplastic left heart syndrome (HLHS). Therapeutic advances for HLHS patients have been hampered by the absence of suitable experimental models. Here, using human induced pluripotent stem cells (hiPSCs), we have generated a series of CRISPR-edited complex heterozygous hypomorphic mutations in NOTCH1 that recapitulate mutations seen in HLHS patients. These cells demonstrate the downregulation of genes associated with mitochondria, the actin cytoskeleton, and cardiomyocyte development. In addition, these hypomorphic NOTCH1 hiPSCs cells showed an increased propensity to differentiate towards non-cardiomyocyte lineages such as fibroblasts and smooth muscle cells, a finding confirmed in HLHS patient-derived myocardial tissue. Abnormalities in sarcomeric and mitochondrial architecture contributed to decreased ATP production, abnormal calcium transients, and reduced contractility. Using a split nano-luciferase system as a NOTCH1 intracellular reporter, we screened a library of FDA-approved compounds. Auranofin, an agent currently employed for rheumatoid arthritis, was identified as a candidate drug that could rescue impaired differentiation and contractility seen in the hypomorphic NOTCH1 model. These findings point to cell-autonomous abnormalities in hypomorphic NOTCH1 pre-cardiomyocyte cells that can be leveraged to identify potential therapeutic strategies for patients with severe congenital cardiac abnormalities. Highlights: CRISPR edited and patient-derived iPSCs with hypomorphic NOTCH1 expression were used to characterize a cell-based model of hypoplastic left heart syndrome. Hypomorphic NOTCH1 iPSCs have abnormalities in pathways associated with mitochondrial function, actin cytoskeleton, and cardiomyocyte development. Hypomorphic NOTCH1 iPSCs have less pluripotency and tend to skew differentiation away from cardiomyocytes and towards fibroblasts and smooth muscle cells. NOTCH1 is required for cardiac cytoskeletal and mitochondrial architecture, and to preserve contractility and ATP production. A high-throughput drug screen identified auranofin as an agent that may benefit patients with hypoplastic left heart syndrome.
- Open Access
- 3 August 2024
- Published by Elsevier in International Journal of Cardiology
- Vol. 414, 132413
Impact of guideline directed medical therapy on myocardial function in adults with congenital heart disease
- 3 August 2024
- Published by Elsevier in International Journal of Cardiology
- Vol. 414, 132413
Open AccessImpact of guideline directed medical therapy on myocardial function in adults with congenital heart disease
- Open Access
Novel 2D/3D Hybrid Organoid System for High-Throughput Drug Screening in iPSC Cardiomyocytes
Human induced pluripotent stem cell cardiomyocytes (hiPSC-CMs) allow for high-throughput evaluation of cardiomyocyte (CM) physiology in health and disease. While multimodality testing provides a large breadth of information related to electrophysiology, contractility, and intracellular signaling in small populations of iPSC-CMs, current technologies for analyzing these parameters are expensive and resource-intensive. We sought to design a 2D/3D hybrid organoid system and harness optical imaging techniques to assess electromechanical properties, calcium dynamics, and signal propagation across CMs in a high-throughput manner. We validated our methods using a doxorubicin-based system, as the drug has well-characterized cardiotoxic, pro-arrhythmic effects. hiPSCs were differentiated into CMs, assembled into organoids, and thereafter treated with doxorubicin. The organoids were then replated to form a hybrid 2D/3D iPSC-CM construct where the 3D cardiac organoids acted as the source of electromechanical activity which propagated outwards into a 2D iPSC-CM sheet. The organoid recapitulated cardiac structure and connectivity, while 2D CMs facilitated analysis at an individual cellular level which recreated numerous doxorubicin-induced electrophysiologic and propagation abnormalities. Thus, we have developed a novel 2D/3D hybrid organoid model that employs an integrated optical analysis platform to provide a reliable high-throughput method for studying cardiotoxicity, providing valuable data on calcium, contractility, and signal propagation.
Open AccessNovel 2D/3D Hybrid Organoid System for High-Throughput Drug Screening in iPSC Cardiomyocytes
Human induced pluripotent stem cell cardiomyocytes (hiPSC-CMs) allow for high-throughput evaluation of cardiomyocyte (CM) physiology in health and disease. While multimodality testing provides a large breadth of information related to electrophysiology, contractility, and intracellular signaling in small populations of iPSC-CMs, current technologies for analyzing these parameters are expensive and resource-intensive. We sought to design a 2D/3D hybrid organoid system and harness optical imaging techniques to assess electromechanical properties, calcium dynamics, and signal propagation across CMs in a high-throughput manner. We validated our methods using a doxorubicin-based system, as the drug has well-characterized cardiotoxic, pro-arrhythmic effects. hiPSCs were differentiated into CMs, assembled into organoids, and thereafter treated with doxorubicin. The organoids were then replated to form a hybrid 2D/3D iPSC-CM construct where the 3D cardiac organoids acted as the source of electromechanical activity which propagated outwards into a 2D iPSC-CM sheet. The organoid recapitulated cardiac structure and connectivity, while 2D CMs facilitated analysis at an individual cellular level which recreated numerous doxorubicin-induced electrophysiologic and propagation abnormalities. Thus, we have developed a novel 2D/3D hybrid organoid model that employs an integrated optical analysis platform to provide a reliable high-throughput method for studying cardiotoxicity, providing valuable data on calcium, contractility, and signal propagation.
- Open Access
- 28 November 2023
- Published by Elsevier in JACC: Advances
- Vol. 3 (1)
Echocardiographic Changes in Hypertensive Disorders of Pregnancy
- 28 November 2023
- Published by Elsevier in JACC: Advances
- Vol. 3 (1)
Open AccessEchocardiographic Changes in Hypertensive Disorders of Pregnancy
- 17 August 2023
- Published by Wiley in Clinical Transplantation
- Vol. 37 (11) , e15101
Long‐Term outcomes in adult patients with congenital heart disease considered for transplantation: A single center study
Background: Adult congenital heart disease (ACHD) patients pose unique challenges in identifying the time for transplantation and factors influencing outcomes.Objective: To identify hemodynamic, functional, and laboratory parameters that correlate with 1‐ and 10‐year outcomes in ACHD patients considered for transplantation.Methods: A retrospective chart review of long‐term outcomes in adult patients with congenital heart disease (CHD) evaluated for heart or heart + additional organ transplant between 2004 and 2014 at our center was performed. A machine learning decision tree model was used to evaluate multiple clinical parameters correlating with 1‐ and 10‐year survival.Results: We identified 58 patients meeting criteria. D‐transposition of the great arteries (D‐TGA) with atrial switch operation (20.7%), tetralogy of Fallot/pulmonary atresia (15.5%), and tricuspid atresia (13.8%) were the most common diagnosis for transplant. Single ventricle patients were most likely to be listed for transplantation (39.8% of evaluated patients). Among a comprehensive list of clinical factors, invasive hemodynamic parameters (pulmonary capillary wedge pressure (PCWP), systemic vascular pressure (SVP), and end diastolic pressures (EDP) most correlated with 1‐ and 10‐year outcomes. Transplanted patients with SVP < 14 and non‐ transplanted patients with PCWP < 15 had 100% survival 1‐year post‐transplantation.Conclusion: For the first time, our study identifies that hemodynamic parameters most strongly correlate with 1‐ and 10‐year outcomes in ACHD patients considered for transplantation, using a data‐driven machine learning model.
- 17 August 2023
- Published by Wiley in Clinical Transplantation
- Vol. 37 (11) , e15101
Long‐Term outcomes in adult patients with congenital heart disease considered for transplantation: A single center study
Background: Adult congenital heart disease (ACHD) patients pose unique challenges in identifying the time for transplantation and factors influencing outcomes.Objective: To identify hemodynamic, functional, and laboratory parameters that correlate with 1‐ and 10‐year outcomes in ACHD patients considered for transplantation.Methods: A retrospective chart review of long‐term outcomes in adult patients with congenital heart disease (CHD) evaluated for heart or heart + additional organ transplant between 2004 and 2014 at our center was performed. A machine learning decision tree model was used to evaluate multiple clinical parameters correlating with 1‐ and 10‐year survival.Results: We identified 58 patients meeting criteria. D‐transposition of the great arteries (D‐TGA) with atrial switch operation (20.7%), tetralogy of Fallot/pulmonary atresia (15.5%), and tricuspid atresia (13.8%) were the most common diagnosis for transplant. Single ventricle patients were most likely to be listed for transplantation (39.8% of evaluated patients). Among a comprehensive list of clinical factors, invasive hemodynamic parameters (pulmonary capillary wedge pressure (PCWP), systemic vascular pressure (SVP), and end diastolic pressures (EDP) most correlated with 1‐ and 10‐year outcomes. Transplanted patients with SVP < 14 and non‐ transplanted patients with PCWP < 15 had 100% survival 1‐year post‐transplantation.Conclusion: For the first time, our study identifies that hemodynamic parameters most strongly correlate with 1‐ and 10‐year outcomes in ACHD patients considered for transplantation, using a data‐driven machine learning model.